{"id":476,"date":"2026-08-28T06:56:06","date_gmt":"2026-08-28T06:56:06","guid":{"rendered":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/"},"modified":"2026-09-01T09:40:18","modified_gmt":"2026-09-01T09:40:18","slug":"aod-9604-options-trial-null-weight-loss-result","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/aod-9604-options-trial-null-weight-loss-result\/","title":{"rendered":"AOD-9604 OPTIONS-Studie: Prim\u00e4res Ergebnis, Nullergebnis und Evidenzgrenzen"},"content":{"rendered":"

AOD-9604 entwickelte sich \u00fcber die Tierarbeit hinaus zu einem Programm zur Entwicklung von Fettleibigkeit. Der 2024-Review von FDA stellt fest, dass die gro\u00dfe OPTIONS-Studie keinen statistisch signifikanten Gewichtsverlust im Vergleich zu Placebo zeigte und dass die Entwicklung zur Behandlung von Fettleibigkeit abgebrochen wurde.<\/p>

Was die Aufzeichnung zeigt<\/h2>
  • Das FDA-Briefing erfasst die registrierten 536-Teilnehmer und die randomisierten 502-Teilnehmer. Eine reproduzierte Sponsorfigur tr\u00e4gt die Aufschrift \u201eAlle Daten N=503\u201c.<\/li>
  • Der Gewichtsverlust im Vergleich zu Placebo in den Wochen 12 und 24 war zu gering, um statistische Signifikanz zu erreichen.<\/li>
  • FDA konnte keine vollst\u00e4ndige Ver\u00f6ffentlichung in einer medizinischen Fachzeitschrift mit den Studienmethoden und vorl\u00e4ufigen Wirksamkeitsdetails finden.<\/li><\/ul><\/div><\/div>
    \"Wissenschaftler
    Originale redaktionelle Darstellung des Forschungskontexts. Es handelt sich nicht um eine Studienfigur, ein Patientenbild, ein Produktfoto oder eine Darstellung von Versuchsmaterial.<\/figcaption><\/figure>

    Studienprotokoll<\/h2>

    Das FDA-Briefing zitiert die Schlussfolgerung des Sponsors, dass die breitere Studienpopulation nicht konsistent reagierte und dass das Ergebnis die kommerzielle Entwicklung von Fettleibigkeit nicht unterst\u00fctzte. Dieser negative Rekord hat mehr Gewicht als vereinzelte Fr\u00fchsignale.<\/p>

    Programm<\/strong>OPTIONS Phase-IIb-Studie zur Entwicklung von Fettleibigkeit<\/span><\/div>
    Eingeschrieben<\/strong>536-Teilnehmer<\/span><\/div>
    Randomisiert<\/strong>502-Teilnehmer in der FDA-Erz\u00e4hlung<\/span><\/div>
    Sponsorenfigur-Etikett<\/strong>Alle Daten, N=503; im FDA-Briefing wiedergegeben<\/span><\/div>
    Prim\u00e4re Interpretation<\/strong>Keine statistisch signifikante Gewichtsabnahme-Unterscheidung gegen\u00fcber Placebo<\/span><\/div>
    Entwicklungsergebnis<\/strong>Adipositas-Programm beendet<\/span><\/div><\/div><\/div>

    Ergebnisse im Kontext<\/h2>

    Die Publikationsl\u00fccke ist wichtig. Ohne einen vollst\u00e4ndigen, von Experten begutachteten Bericht k\u00f6nnen die Leser nicht alle vorgegebenen Analysen, den Umgang mit fehlenden Daten und Untergruppenentscheidungen unabh\u00e4ngig pr\u00fcfen.<\/p>

    AOD-9604 sollte daher als experimentelles GH-Fragment mit einem fehlgeschlagenen Endpunkt zur Entwicklung von Fettleibigkeit beschrieben werden \u2013 und nicht als klinisch erprobtes \u201eFettverbrennungspeptid\u201c.<\/p>

    Was diese Studie nicht beantworten kann<\/h2>

    Die wichtigsten Details zu gro\u00dfen Studien finden sich in beh\u00f6rdlichen und unternehmensinternen Aufzeichnungen und nicht in einem vollst\u00e4ndigen, von Experten begutachteten Studienbericht.<\/p>

    Das Versagen bei der Entwicklung von Fettleibigkeit beantwortet nicht alle Laborfragen, widerspricht jedoch direkt den selbstbewussten Behauptungen zur Gewichtsabnahme beim Menschen.<\/p>","protected":false},"excerpt":{"rendered":"

    AOD-9604 entwickelte sich \u00fcber die Tierarbeit hinaus zu einem Programm zur Entwicklung von Fettleibigkeit. Der 2024-Review von FDA stellt fest, dass die gro\u00dfe OPTIONS-Studie keinen statistisch signifikanten Gewichtsverlust im Vergleich zu Placebo zeigte und dass die Entwicklung zur Behandlung von Fettleibigkeit abgebrochen wurde.<\/p>","protected":false},"author":1,"featured_media":641,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"314","pim_article_type":"Published study case","pim_evidence_level":"FDA-reviewed development record; pivotal result not published as a full journal trial","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"FDA December 2024 AOD-9604 briefing document\",\"url\":\"https:\/\/www.fda.gov\/media\/183584\/download\",\"note\":\"FDA review of effectiveness, safety and the OPTIONS result.\"},{\"title\":\"AOD-9604 development review\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15134286\/\",\"note\":\"Contemporaneous development summary; PMID 15134286.\"},{\"title\":\"FDA December 2024 PCAC meeting record\",\"url\":\"https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy\",\"note\":\"Regulatory meeting context.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-476","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\nAOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits - NHD<\/title>\n<meta name=\"description\" content=\"AOD-9604 progressed beyond animal work into an obesity-development program. FDA\u2019s 2024 review records that the large OPTIONS study did not show statistical\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/aod-9604-options-trial-null-weight-loss-result\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits\" \/>\n<meta property=\"og:description\" content=\"AOD-9604 progressed beyond animal work into an obesity-development program. FDA\u2019s 2024 review records that the large OPTIONS study did not show statistical\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/aod-9604-options-trial-null-weight-loss-result\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T09:40:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits\",\"datePublished\":\"2026-08-28T06:56:06+00:00\",\"dateModified\":\"2026-09-01T09:40:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/\"},\"wordCount\":283,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/\",\"name\":\"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits - NHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:06+00:00\",\"dateModified\":\"2026-09-01T09:40:18+00:00\",\"description\":\"AOD-9604 progressed beyond animal work into an obesity-development program. FDA\u2019s 2024 review records that the large OPTIONS study did not show statistical\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AOD-9604 OPTIONS-Studie: Prim\u00e4res Ergebnis, Nullergebnis und Evidenzgrenzen \u2013 NHD","description":"AOD-9604 entwickelte sich \u00fcber die Tierarbeit hinaus zu einem Programm zur Entwicklung von Fettleibigkeit. Der 2024-Review von FDA stellt fest, dass die gro\u00dfe OPTIONS-Studie keine statistischen Ergebnisse erbrachte.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/aod-9604-options-trial-null-weight-loss-result\/","og_locale":"de_DE","og_type":"article","og_title":"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits","og_description":"AOD-9604 progressed beyond animal work into an obesity-development program. FDA\u2019s 2024 review records that the large OPTIONS study did not show statistical\u2026","og_url":"https:\/\/nhdbio.com\/de\/aod-9604-options-trial-null-weight-loss-result\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:06+00:00","article_modified_time":"2026-09-01T09:40:18+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits","datePublished":"2026-08-28T06:56:06+00:00","dateModified":"2026-09-01T09:40:18+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/"},"wordCount":283,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp","articleSection":["Published Study Reviews"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/","url":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/","name":"AOD-9604 OPTIONS-Studie: Prim\u00e4res Ergebnis, Nullergebnis und Evidenzgrenzen \u2013 NHD","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp","datePublished":"2026-08-28T06:56:06+00:00","dateModified":"2026-09-01T09:40:18+00:00","description":"AOD-9604 entwickelte sich \u00fcber die Tierarbeit hinaus zu einem Programm zur Entwicklung von Fettleibigkeit. Der 2024-Review von FDA stellt fest, dass die gro\u00dfe OPTIONS-Studie keine statistischen Ergebnisse erbrachte.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/476","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=476"}],"version-history":[{"count":3,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/476\/revisions"}],"predecessor-version":[{"id":713,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/476\/revisions\/713"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/641"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=476"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=476"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}